Nasolabial Folds Clinical Trial
Official title:
Protocol for the Post-approval Study of ArteFill® for Correction of Nasolabial Folds
The purpose of this post-approval study is to evaluate the continuing safety of ArteFill as an injectable implant for correction of nasolabial folds over the course of five years post implantation, with a focus on determining the incidence of granuloma formation. Incidence of adverse events and subject satisfaction with respect to the subject's personal expectations will be assessed.
This study is a multi-center, non-randomized, non-controlled post-approval study designed to follow a total of 1000 consecutive qualified and consenting subjects treated with ArteFill in the course of clinical practice at approximately twenty-five centers. All potential qualifying subjects at a given site should be given the opportunity to participate in the study. Inclusion and exclusion criteria will be limited to those in the approved labeling for ArteFill and treatment will be according to the approved product labeling. Subjects must have a previously documented negative skin test prior to treatment. ;
Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT06018987 -
A Study to Assess Adverse Events and Effectiveness of HAC 20L Injections in Adult Participants for the Treatment of Nasolabial Folds
|
Phase 2/Phase 3 | |
Completed |
NCT01012661 -
Evaluation of Pain With Lidocaine-Mixed Radiesse® Injectable Dermal Filler
|
Phase 4 | |
Completed |
NCT01115634 -
Autologous Fibroblast Transplantation in Facial Deformities
|
Phase 2 | |
Completed |
NCT03932045 -
A Study to Evaluate the Safety and Efficacy of SYB Filler(SF-01) in the Correction of Nasolabial Folds
|
N/A | |
Completed |
NCT02647853 -
Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT01069354 -
Evaluation of Pain With Radiesse® With Lidocaine for Nasolabial Folds
|
N/A | |
Completed |
NCT00797459 -
Safety & Tolerability Study That Compares Restylane to Restylane With Lidocaine While Correcting Wrinkles in the Nasolabial Folds
|
N/A | |
Completed |
NCT00850889 -
Juvederm Ultra With Lidocaine Compared With Restylane for the Correction of Nasolabial Folds
|
Phase 4 | |
Recruiting |
NCT06093321 -
A Study Comparing SYB PDO Thread and MINT Lift® for Temporary Nasolabial Fold Improvement
|
N/A | |
Not yet recruiting |
NCT06295172 -
A Study Comparing Lafullen15 and Lafullen for Temporary Nasolabial Fold Improvement
|
N/A | |
Completed |
NCT01060943 -
An Efficacy and Safety Study of TheraFill® Versus KOKEN for 3 Months on Nasolabial Folds
|
Phase 3 | |
Completed |
NCT05612958 -
Efficacy and Safety of a 'Graft/Prosthesis, Biomaterial (DKM410)' in the Treatment of Both Nasolabial Folds
|
N/A | |
Completed |
NCT02672644 -
Non-comparative Evaluation of Facial Expressions Following Lower Face Correction Using Emervel Classic and Emervel Deep
|
Phase 4 | |
Completed |
NCT01012388 -
Radiesse® Injectable Dermal Filler for the Treatment of Nasolabial Folds in Persons of Color
|
Phase 4 | |
Completed |
NCT01635855 -
Belotero Post Approval Study
|
Phase 4 | |
Completed |
NCT02179736 -
A Post Market Evaluation After Treatment of Nasolabial Folds
|
N/A | |
Terminated |
NCT00716443 -
Evaluate Efficacy, Safety & Subject Satisfaction of Pain Management With Pliaglis® Cream for Dermal Filler Injections
|
Phase 4 | |
Recruiting |
NCT02607670 -
Phase 2 Study of TAT4 Gel for Reduction of Nasolabial Folds
|
Phase 2 | |
Completed |
NCT00823069 -
Safety Study That Compares Perlane to Perlane With Lidocaine (Perlane-L) While Correcting Wrinkles in the Area Around Your Nose
|
N/A | |
Recruiting |
NCT06367634 -
TEOSYAL® PureSense ULTRA DEEP Versus Restylane® Lidocaine for the Correction of Moderate to Severe Nasolabial Folds in Chinese Adults
|
N/A |